Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.
A transformative new scholarship program established by Weill Cornell Medicine will eliminate medical education debt for all students who qualify for financial aid.
Dr. Geraldine McGinty, chief strategy officer of Weill Cornell Medicine’s Physician Organization, has been named the 2019 recipient of the Jessica M. and Natan Bibliowicz Award for Excellence in Mentoring Women Faculty.
With a $7.5 million gift from the Friedman Family Foundation endowed by Stephen and Vice Chair Overseer Barbara Friedman, Weill Cornell Medicine has established an innovative cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.
For Weill Cornell Medicine, 1998 was a banner year. Amid its centennial celebration, the academic medical institution renamed itself in deep appreciation for Joan and Sanford I. Weill and their exemplary leadership, launching a bright, new era of dynamic expansion.
Mark Veich, an accomplished leader in institutional advancement, has been appointed vice provost for external affairs at Weill Cornell Medicine, effective Feb. 12.
After 20 years of bold and visionary leadership, Sanford I. Weill will retire as chair of the Weill Cornell Board of Overseers. Jessica M. Bibliowicz, successful business executive, named new chair of the board.
